Ameriprise Financial Inc Ovid Therapeutics Inc. Transaction History

Ameriprise Financial Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$2.42 - $6.6 $188,842 - $515,024	-78,034 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$5.6 - $11.0 $651,436 - $1.28 Million	-116,328 Reduced 59.85%	78,034 $443,000
Q2 2018 Aug 14, 2018	SELL	$6.16 - $10.14 $81,250 - $133,746	-13,190 Reduced 6.36%	194,362 $1.51 Million
Q1 2018 May 15, 2018	SELL	$6.53 - $9.82 $50,901 - $76,546	-7,795 Reduced 3.62%	207,552 $1.47 Million
Q4 2017 Feb 12, 2018	SELL	$6.12 - $12.31 $516,711 - $1.04 Million	-84,430 Reduced 28.16%	215,347 $2.13 Million
Q3 2017 Nov 07, 2017	BUY	$5.32 - $9.77 $1.59 Million - $2.93 Million	299,777	299,777 $2.57 Million

39M

37.4K

500

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $73.2M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.